“…For example, several reports have elucidated the role of NK cells in killing cancer cells in murine models of melanoma, colon cancer, lung cancer, and breast cancer (Azogui et al, 1991; Pham-Nguyen et al, 1999; Velthuis et al, 2003; Carrega et al, 2009; Frings et al, 2011; Kim et al, 2011; Takeda et al, 2011; Vesely et al, 2011; Roberti et al, 2012a; Srivastava et al, 2012). There are several NK receptors, such as DNAM-1, CD155, CD16, CD69, NKp30, and NKp46, whose surface expression is fundamental for maintaining cancer immunosurveillance (Clausen et al, 2003; Garcia-Iglesias et al, 2009; Lakshmikanth et al, 2009; Chan et al, 2010; Levy et al, 2011; Pfeiffer et al, 2011; Gleason et al, 2012; Park et al, 2012a).…”